Free Trial

Avanos Medical (AVNS) Stock Price, News & Analysis

$20.36
+0.07 (+0.35%)
(As of 05/22/2024 ET)
Today's Range
$20.17
$20.37
50-Day Range
$17.85
$20.41
52-Week Range
$17.24
$26.56
Volume
149,768 shs
Average Volume
263,790 shs
Market Capitalization
$934.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Avanos Medical MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.16% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.71mentions of Avanos Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$152,960 Sold Last Quarter
Proj. Earnings Growth
31.88%
From $1.38 to $1.82 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.54 out of 5 stars

Medical Sector

265th out of 919 stocks

Surgical Appliances & Supplies Industry

9th out of 18 stocks

AVNS stock logo

About Avanos Medical Stock (NYSE:AVNS)

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

AVNS Stock Price History

AVNS Stock News Headlines

Avanos Medical: Q1 Earnings Snapshot
AVNS Mar 2024 20.000 call
Avanos Medical Q4 2023 Earnings Preview
Avanos Medical, Inc. (AVNS)
See More Headlines
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/02/2024
Today
5/22/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Fax
N/A
Employees
3,771
Year Founded
N/A

Profitability

Net Income
$-61,800,000.00
Pretax Margin
0.40%

Debt

Sales & Book Value

Annual Sales
$673.30 million
Cash Flow
$2.03 per share
Book Value
$26.75 per share

Miscellaneous

Free Float
44,095,000
Market Cap
$934.52 million
Optionable
Optionable
Beta
0.97
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Joseph F. Woody (Age 58)
    CEO & Director
    Comp: $2.21M
  • Mr. Michael C. Greiner (Age 51)
    Senior VP, CFO & Chief Transformation Officer
    Comp: $986.42k
  • Ms. Mojirade James (Age 57)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $728.66k
  • Mr. Kerr W. Holbrook (Age 57)
    Senior VP & Chief Commercial Officer
    Comp: $747.61k
  • Mr. Sudhakar Varshney (Age 47)
    Senior Vice President of Global Supply Chain & Procurement
    Comp: $1.02M
  • Mr. John Joseph Hurley
    Principal Accounting Officer & Controller
  • Mr. David Crawford
    VP of FP&A and Investor Relations and Treasurer
  • Ms. Michelle Scharfenberg
    Senior VP and Chief Ethics & Compliance Officer
  • Mr. Scott Galovan
    Vice President of Strategy & Corporate Development
  • John W. Cato
    Vice President of Human Resources

AVNS Stock Analysis - Frequently Asked Questions

Should I buy or sell Avanos Medical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares.
View AVNS analyst ratings
or view top-rated stocks.

How have AVNS shares performed in 2024?

Avanos Medical's stock was trading at $22.43 at the beginning of 2024. Since then, AVNS stock has decreased by 9.3% and is now trading at $20.3550.
View the best growth stocks for 2024 here
.

Are investors shorting Avanos Medical?

Avanos Medical saw a decline in short interest in April. As of April 30th, there was short interest totaling 968,300 shares, a decline of 17.2% from the April 15th total of 1,170,000 shares. Based on an average daily volume of 240,100 shares, the short-interest ratio is presently 4.0 days. Currently, 2.2% of the company's stock are short sold.
View Avanos Medical's Short Interest
.

When is Avanos Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our AVNS earnings forecast
.

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) released its quarterly earnings results on Thursday, May, 2nd. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by $0.02. The business had revenue of $166.10 million for the quarter, compared to analysts' expectations of $162.90 million. Avanos Medical had a negative net margin of 9.15% and a positive trailing twelve-month return on equity of 4.10%. The company's revenue for the quarter was up 4.3% on a year-over-year basis. During the same period last year, the company earned $0.27 earnings per share.

What ETF holds Avanos Medical's stock?

Invesco S&P SmallCap Health Care ETF holds 83,669 shares of AVNS stock, representing 0.78% of its portfolio.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical issued an update on its FY 2024 earnings guidance on Friday, May, 3rd. The company provided EPS guidance of 1.300-1.450 for the period, compared to the consensus estimate of 1.380. The company issued revenue guidance of $685.0 million-$705.0 million, compared to the consensus revenue estimate of $691.0 million.

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?

32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), RTX (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.76%), Westwood Holdings Group Inc. (4.61%), William Blair Investment Management LLC (3.10%), Paradice Investment Management LLC (2.78%), Tributary Capital Management LLC (1.61%) and Principal Financial Group Inc. (0.56%). Insiders that own company stock include Julie Ann Shimer, Michael Greiner and Patrick J Oleary.
View institutional ownership trends
.

How do I buy shares of Avanos Medical?

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AVNS) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners